Reata Pharmaceuticals (RETA) Earnings
|
Expand Research on RETA
| Next EPS Date | N/A | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +33.0% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | -4.4% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/7/23 | Q323 | N/A | -$2.14 | N/A | N/A | $19.81M | N/A | N/A | N/A | ||
| 8/21/23 | Q223 | N/A | -$0.48 | N/A | N/A | $22.72M | N/A | N/A | N/A | ||
| 8/7/23 | Q223 | N/A | -$2.76 | N/A | N/A | $141.67K | N/A | N/A | N/A | ||
| 8/28/23 | Q223 | N/A | -$0.48 | N/A | N/A | $22.72M | N/A | N/A | N/A | ||
| 5/10/23 | Q123 | -$1.81 | -$2.41 | +$0.60 | $200K | $191.43K | N/A |  | | Details | |
| 3/3/23 | Q422 | N/A | -$2.19 | N/A | N/A | $491.43K | N/A | N/A | N/A | ||
| 3/6/23 | Q422 | N/A | -$2.32 | N/A | N/A | $491.43K | N/A | N/A | N/A | ||
| 3/27/23 | Q422 | N/A | -$2.32 | N/A | N/A | $491.43K | N/A | N/A | N/A |
